Search results
Results From The WOW.Com Content Network
Candida auris has attracted increased clinical attention because of its multiple drug resistance. [6] [7] [4]In vitro, more than 90% of C. auris isolates are resistant to fluconazole [8] [9] and a range of 3–73% of C. auris isolates are resistant to voriconazole, [9] [10] while other triazoles (posaconazole, itraconazole, and isavuconazole) display better activity.
A drug-resistant and potentially deadly fungus has been spreading rapidly through U.S. health care facilities, a new government study finds. The fungus, a type of yeast called Candida auris, or C ...
The researchers found 3,270 clinical cases and 7,413 screening cases of C auris, noting that there was a 44% year-over-year increase in cases in 2019, and a 95% increase in cases in 2021. From ...
Invasive candidiasis is an infection (candidiasis) that can be caused by various species of Candida yeast. Unlike Candida infections of the mouth and throat (oral candidiasis) or vagina (Candidal vulvovaginitis), invasive candidiasis is a serious, progressive, and potentially fatal infection that can affect the blood (), heart, brain, eyes, bones, and other parts of the body.
A potentially deadly strain of fungus is spreading at "an alarming rate" and has shown resistance to multiple antifungal medications, the CDC warned.
Candidiasis is a fungal infection due to any species of the genus Candida (a yeast). [4] When it affects the mouth, in some countries it is commonly called thrush. [3] Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. [3]
Yet, there is an increasing incidence of infections caused by C. glabrata and C. rugosa, which could be because they are frequently less susceptible to the currently used azole-group of antifungals. [25] Other medically important species include C. parapsilosis, C. tropicalis, C. dubliniensis. [8] and the more recently emerging pathogen C ...
For premium support please call: 800-290-4726 more ways to reach us